Latest Pharmos trial flop sends share tumbling Globes Pharmos reported that although the primary efficacy variable (percentage of weeks responding for adequate overall relief of IBS symptoms) did not reach ...
Double advantage management programme Times of India The institute's brochure says IBS-Bangalore doesn't offer a degree or diploma, hence it hasn't sought for AICTE recognition, which is needed to start a PGDM ...
Napo Gathers International Panel on Global Health Business Wire (press release) The FDA has granted fast-track status to crofelemer development for IBS and HIV-related indications (CRO-IBS and CRO-HIV): Napo's licensee, ...